PAR2

PAR2

PAR2 Informations sur la molécule

Molecule Name
Protease-activated receptor-2
Alias de la molécule
PAR2
Drug Development Progress
Nombre de médicaments cliniques3
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
Receptor, PAR-2,F2RL1,Thrombin receptor-like 1,G-protein coupled receptor 11,F2R Like Trypsin Receptor 1,PAR2,GPR11,Protease-Activated Receptor 2,Coagulation Factor II (Thrombin) Receptor-Like 1,Proteinase-Activated Receptor-2,Proteinase-activated receptor 2,Coagulation factor II receptor-like 1
Contexte de la molécule
This gene encodes a member of the G-protein coupled receptor 1 family of proteins. The encoded cell surface receptor is activated through proteolytic cleavage of its extracellular amino terminus, resulting in a new amino terminus that acts as a tethered ligand that binds to an extracellular loop domain. Activation of the receptor has been shown to stimulate vascular smooth muscle relaxation, dilate blood vessels, increase blood flow, and lower blood pressure. This protein is also important in the inflammatory response, as well as innate and adaptive immunity. [provided by RefSeq, Jun 2016]

PAR2 Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
MEDI-0618MEDI-0618; MEDI0618; ABBV-2002; ABBV2002Phase 2 ClinicalAstrazeneca Plc
Chronic Pain; Migraine Disorders
Details
TEV-56192TEV-56192Phase 1 ClinicalTeva Pharmaceutical Industries Ltd
Nervous System Diseases
Details
OA-235iOA-235iPhase 1 ClinicalOasis Pharmaceuticals LLC
Metabolic Dysfunction-Associated Steatotic Liver Disease
Details